Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S Knudsen

Showing results (171-180 of 505) with videos related to

Pageof 51
Sort By:
Journal of Cell Science|September 10, 2016
A basal cell defect promotes budding of prostatic intraepithelial neoplasiaMengdie Wang, Raymond B Nagle, Beatrice S Knudsen, et al.
JAMA Network Open|February 8, 2020
Differences Between Randomized Clinical Trial Participants and Real-World Empagliflozin Users and the Changes in Their Glycated Hemoglobin LevelsNicolai E Munk, Jakob S Knudsen, Anton Pottegård, et al.
Bioinformatics (Oxford, England)|January 12, 2018
Sensitive and specific post-call filtering of genetic variants in xenograft and primary tumorsBrian K Mannakee, Uthra Balaji, Agnieszka K Witkiewicz, et al.
Genes & Development|August 8, 1998
Inhibition of DNA synthesis by RB: effects on G1/S transition and S-phase progressionE S Knudsen, C Buckmaster, T T Chen, et al.
The Journal of Biological Chemistry|August 15, 1986
Binding of plasminogen to extracellular matrixB S Knudsen, R L Silverstein, L L Leung, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 20, 2012
RB-pathway disruption is associated with improved response to neoadjuvant chemotherapy in breast cancerAgnieszka K Witkiewicz, Adam Ertel, Jeanne McFalls, et al.
Cancer Research|December 10, 2009
The aryl hydrocarbon receptor functions as a tumor suppressor of liver carcinogenesisYunxia Fan, Gregory P Boivin, Erik S Knudsen, et al.
Journal of Pathology Informatics|February 23, 2023
Predicting IHC staining classes of NF1 using features in the hematoxylin channelWei Zhang, Mei Yee Koh, Deepika Sirohi, et al.
Diabetes, Obesity & Metabolism|November 3, 2020
Real-world use of cardioprotective glucose-lowering drugs in patients with type 2 diabetes and cardiovascular disease: A Danish nationwide cohort study, 2012 to 2019Kristian L Funck, Jakob S Knudsen, Troels K Hansen, et al.
Trends in Cancer|June 9, 2019
Cell Cycle and Beyond: Exploiting New RB1 Controlled Mechanisms for Cancer TherapyErik S Knudsen, Steven C Pruitt, Pamela A Hershberger, et al.
Pageof 51

Showing results (171-180 of 505) with videos related to

Sort By:
Pageof 51
Journal of Cell Science|September 10, 2016
A basal cell defect promotes budding of prostatic intraepithelial neoplasiaMengdie Wang, Raymond B Nagle, Beatrice S Knudsen, et al.
JAMA Network Open|February 8, 2020
Differences Between Randomized Clinical Trial Participants and Real-World Empagliflozin Users and the Changes in Their Glycated Hemoglobin LevelsNicolai E Munk, Jakob S Knudsen, Anton Pottegård, et al.
Bioinformatics (Oxford, England)|January 12, 2018
Sensitive and specific post-call filtering of genetic variants in xenograft and primary tumorsBrian K Mannakee, Uthra Balaji, Agnieszka K Witkiewicz, et al.
Genes & Development|August 8, 1998
Inhibition of DNA synthesis by RB: effects on G1/S transition and S-phase progressionE S Knudsen, C Buckmaster, T T Chen, et al.
The Journal of Biological Chemistry|August 15, 1986
Binding of plasminogen to extracellular matrixB S Knudsen, R L Silverstein, L L Leung, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 20, 2012
RB-pathway disruption is associated with improved response to neoadjuvant chemotherapy in breast cancerAgnieszka K Witkiewicz, Adam Ertel, Jeanne McFalls, et al.
Cancer Research|December 10, 2009
The aryl hydrocarbon receptor functions as a tumor suppressor of liver carcinogenesisYunxia Fan, Gregory P Boivin, Erik S Knudsen, et al.
Journal of Pathology Informatics|February 23, 2023
Predicting IHC staining classes of NF1 using features in the hematoxylin channelWei Zhang, Mei Yee Koh, Deepika Sirohi, et al.
Diabetes, Obesity & Metabolism|November 3, 2020
Real-world use of cardioprotective glucose-lowering drugs in patients with type 2 diabetes and cardiovascular disease: A Danish nationwide cohort study, 2012 to 2019Kristian L Funck, Jakob S Knudsen, Troels K Hansen, et al.
Trends in Cancer|June 9, 2019
Cell Cycle and Beyond: Exploiting New RB1 Controlled Mechanisms for Cancer TherapyErik S Knudsen, Steven C Pruitt, Pamela A Hershberger, et al.
Pageof 51